• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 0.13% Nasdaq Down 0.81%

    Merrimack Pharmaceuticals, Inc. (MACK)

    -NasdaqGM
    11.61 Down 0.51(4.21%) 10:24AM EDT - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:12.12
    Open:12.08
    Bid:11.61 x 500
    Ask:11.64 x 200
    1y Target Est:15.20
    Beta:1.28
    Next Earnings Date: 7-May-15MACK Earnings announcement
    Day's Range:11.53 - 12.11
    52wk Range:5.53 - 13.84
    Volume:222,293
    Avg Vol (3m):1,359,330
    Market Cap:1.25B
    P/E (ttm):N/A
    EPS (ttm):-0.80
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for MACK

    Comparison

    Symbol% ChgMkt Cap
    MACKDown 4.21%1.25B
    IMMUDown 3.37%348.33M
    LRUSF 0.00%N/A
    THLDUp 0.29%249.66M

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):12.61
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-0.97
    Quarterly EPS Est (Mar-15) :-0.29
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):-2.19

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, engages in discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer primarily in the United States. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback